Featured Program
Featured Resources
Featured Advocacy Letters
NCL Sends Letter to Senate HELP Committee on Lowering Healthcare Costs
/in Featured Home - Health/by allisoncAugust 1, 2025: Washington, DC – On July 31, 2025, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing on the rising cost of healthcare and the urgent need for patient-focused reform. Lawmakers and expert witnesses discussed challenges with employer-sponsored insurance, the lack of price transparency, and the profit-driven nature of the U.S. healthcare system.
Featured Press Releases
Maine Strengthens Consumer Protections Against Predatory Medical Debt National Consumers League Applauds Governor Janet Mills and the Maine Legislature
/in Featured Home - Health/by allisoncApril 8, 2026: Washington, DC — The National Consumers League applauds Governor Janet Mills and the Maine legislature for their notable legislation to stem the destructive effects of medical debt collection practices.
March Madness Frenzy: Consumers Beware—Sports Betting Apps Are Draining Your Credit
/in Featured Home - Consumer Protection/by Lisa McDonaldApril 2, 2026: Washington, DC — As March Madness reaches the Final Four—with billions of dollars on the line and millions of Americans placing high-stakes wagers—the National Consumers League (NCL) is warning that sports betting apps are doing more than fueling the excitement—they may be quietly draining consumers’ savings and damaging their financial health.
National Consumers League Applauds Progress on Responsible GLP-1 Marketing
/in Featured Home - Food, Nutrition, & Obesity/by Lisa McDonaldMarch 9, 2026: Washington, DC – As an organization focused on the safety of GLP-1 weight-loss drugs, the National Consumers League welcomes the agreement between Novo Nordisk and the telehealth platform Hims & Hers as an important step that could turn the tide away from consumers opting for unapproved GLP-1 weight-loss products.
National Consumers League Commends FDA for Swift Action Against Hims & Hers
/in Featured Home - Food, Nutrition, & Obesity/by Lisa McDonaldFebruary 9, 2026: Washington, DC – You can fool some of the people some of the time and all of the people some of the time. But you can’t fool all of the people all the time. On Friday, February 6, the Food and Drug Administration announced it would stop the telehealth platform Hims & Hers from marketing a compounded version of the first FDA-approved GLP-1 weight-loss pill. On Saturday, Hims & Hers said it was withdrawing the product from the market, and the FDA did not pursue enforcement action.